Handelsavisen
prelaunch
Companies Basic Materials 603041.SS
60
603041.SS Shanghai Stock Exchange Specialty Chemicals

Jiangsu Maysta Chemical Co Ltd

¥14,36
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
2,6B CNY
P/E
42,7x
EV / Rev
3,9x
Div yield
0,85 %
Op margin
20,0 %
ROE
1,7 %
Net margin
17,7 %
Debt / equity
0,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Jiangsu Maysta Chemical Co Ltd is a specialty chemicals manufacturer that produces and sells chemical products, primarily for industrial applications.

Business. Jiangsu Maysta Chemical Co Ltd (603041.SS) is a specialty chemicals manufacturer headquartered in China. The company operates within the Basic Materials sector, specifically focusing on the production and sale of chemical products. It is primarily listed on the Shanghai Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustrySpecialty Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
42,7x
P/E
Analysts
not yet wired
Ownership
not yet wired
Profitability
1,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 603041.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 603041.SS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Jiangsu Maysta Chemical Co Ltd (603041.SS) is a specialty chemicals manufacturer headquartered in China. The company operates within the Basic Materials sector, specifically focusing on the production and sale of chemical products. It is primarily listed on the Shanghai Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustrySpecialty Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Jiangsu Maysta Chemical Co Ltd maintains a strong liquidity position with a current ratio of 3.59, indicating the company can cover its short-term obligations more than three times over. The company's liquidity is further supported by a low debt-to-equity ratio of 0.01, suggesting minimal reliance on debt financing. However, the company's net cash position is negative after subtracting total debt, which introduces a medium liquidity risk.

    In terms of profitability, the company's return on equity (ROE) is 1.74%, and its return on assets (ROA) is 1.46%, both of which are below the typical thresholds for high-performing specialty chemical firms. The company's gross profit margin is 40.0%, and its operating margin is 20.0%, which are in line with the industry's median profitability metrics. However, the company's net income margin is 17.7%, which is slightly below the industry median, indicating some inefficiencies in cost management or pricing power.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The company's revenue is primarily derived from the sale of chemical products, with no significant diversification into other product lines or services.

    Looking at the company's growth trajectory, the current fiscal year is expected to show a modest increase in revenue, with a projected growth rate of 2.0% year-over-year. The next fiscal year is expected to see a similar growth rate, with a projected increase of 2.0%. The company's capital expenditures are negative, indicating a reduction in investment in new projects or facilities, which may signal a focus on cost optimization rather than expansion.

    The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which introduces a medium liquidity risk. The company's dilution risk is low, as there is no indication of significant share issuance or dilution potential. The company's financial structure is relatively stable, with a low debt-to-equity ratio and a strong current ratio.

    Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's recent financial performance and capital structure suggest a conservative approach to growth and risk management. There are no recent regulatory changes or geopolitical events that have significantly impacted the company's operations.

    Key takeaways
    • Jiangsu Maysta Chemical Co Ltd has a strong liquidity position with a current ratio of 3.59 and a low debt-to-equity ratio of 0.01.
    • The company's profitability metrics, including ROE and ROA, are below the industry median, indicating room for improvement in cost management and pricing power.
    • The company's revenue is concentrated in a single business segment, increasing its exposure to regional economic fluctuations.
    • The company is expected to show modest revenue growth in the current and next fiscal years, with a projected growth rate of 2.0% year-over-year.
    • The company's risk assessment indicates a medium liquidity risk and a low dilution risk, with a stable financial structure.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Debt-to-equity ratio of 0.01 is well below the 0.23 cohort median, reflecting a conservative capital structure.

    Cash conversion of 1.55 exceeds the 1.08 cohort median, demonstrating strong efficiency in generating cash from earnings.

    Revenue grew 5.4% annually over four years, showing consistent top-line expansion despite recent net income volatility.

    BEAR CASE · 3

    Return on equity of 1.7% falls below the 3.9% cohort median, indicating inefficient use of shareholder capital.

    Free cash flow turned negative in three of the last five periods, raising concerns about cash generation stability.

    Liquidity risk is rated as medium, indicating potential challenges in meeting short-term financial obligations.

    In focus — financials by report

    Annual
    ANNUALFiled 2024-04-26
    FY 2024 · Full-year highlights

    Revenue ¥501.0M, +0,8% YoY; Operating income +43,5% YoY.

    Revenue¥501.0M+0,8 % YoY
    Operating income¥128.4M+43,5 % YoY
    Net income¥110.0M+39,4 % YoY
    Free cash flow-¥104.1M+15,2 % YoY
    EPS
    Operating cash flow¥65.6M−10,8 % YoY
    Financials
    Income statement
    Revenue¥501.0M
    Gross profit¥192.1M
    Operating income¥128.4M
    Net income¥110.0M
    Margins
    Gross margin38.3%
    Operating margin25.6%
    Net margin22.0%
    FCF margin-20.8%
    Balance sheet
    Total assets¥1.75B
    Total liabilities¥293.2M
    Total equity¥1.46B
    Cash & equivalents
    Long-term debt¥6.1M
    Cash flow
    Operating cash flow¥65.6M
    CapEx-¥207.9M
    Free cash flow-¥104.1M
    SBC
    P&L flow · revenue → net income
    Revenue ¥145.9MOperating costs ¥116.6MNet income ¥25.8M
    Highlights
    • Revenue ¥501.0M, +0,8% YoY
    • Operating income +43,5% YoY
    • Net income +39,4% YoY
    • Free cash flow +15,2% YoY
    • Net margin 22.0%

    Valuation FY

    Market price
    ¥14,36
    Market cap
    ¥2.42B
    Enterprise value
    ¥2.44B
    P/E
    42.7x
    Non-GAAP P/E
    EV / Revenue
    3.9x
    EV / Op income
    32.4x
    EV / OCF
    61.1x
    P / B
    1.6x
    P / Tangible book
    1.6x
    Tangible book
    ¥1.48B
    Net cash
    -¥20.4M
    Current ratio
    3.6
    Debt / equity
    0.0
    ROA
    1.5%
    ROE
    1.7%
    Cash conversion
    155.0%
    CapEx / revenue
    -20.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin20,0 %Best in class
    Net Margin17,7 %Best in class
    ROE1,7 %Below median
    Capex / Rev-20,0 %Bottom quartile
    D/E0,01Above P75
    Cash Conv1,55Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Jiangsu Maysta Chemical Co Ltd Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    603041.SSCanonical
    Shanghai Stock Exchange · CNY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2024-04-26 18:18 UTCEARNINGSAnnual results — FY 2024 Revenue CNY 501.0M · Net CNY 110.0M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage